Literature DB >> 18272890

The B cell--old player, new position on the team.

Henry F McFarland1.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18272890     DOI： 10.1056/NEJMp0708143

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  19 in total

1.  Indications of rituximab in autoimmune diseases.

Authors:  Iñaki Sanz
Journal:  Drug Discov Today Ther Strateg       Date:  2009-04-01

Review 2.  Progressive multifocal leukoencephalopathy and newer biological agents.

Authors:  Joseph R Berger
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

3.  Escalating immunotherapy of multiple sclerosis.

Authors:  Peter Rieckmann; Anthony Traboulsee; Virginia Devonshire; Joel Oger
Journal:  Ther Adv Neurol Disord       Date:  2008-11       Impact factor: 6.570

4.  Rituximab induces clinical stabilization in a patient with fulminant multiple sclerosis not responding to natalizumab. Evidence for disease heterogeneity.

Authors:  Verena I Leussink; Helmar C Lehmann; Gerd Meyer zu Hörste; Hans-Peter Hartung; Olaf Stüve; Bernd C Kieseier
Journal:  J Neurol       Date:  2008-07-17       Impact factor: 4.849

5.  A unique antibody gene signature is prevalent in the central nervous system of patients with multiple sclerosis.

Authors:  A J Ligocki; L Lovato; D Xiang; P Guidry; R H Scheuermann; S N Willis; S Almendinger; M K Racke; E M Frohman; D A Hafler; K C O'Connor; N L Monson
Journal:  J Neuroimmunol       Date:  2010-07-23       Impact factor: 3.478

Review 6.  B cells and immunological tolerance.

Authors:  Nataly Manjarrez-Orduño; Tâm D Quách; Iñaki Sanz
Journal:  J Invest Dermatol       Date:  2009-02       Impact factor: 8.551

7.  Development of ALS-like disease in SOD-1 mice deficient of B lymphocytes.

Authors:  Shulamit Naor; Zohar Keren; Tomer Bronshtein; Efrat Goren; Marcelle Machluf; Doron Melamed
Journal:  J Neurol       Date:  2009-03-12       Impact factor: 4.849

Review 8.  Insights into the heterogeneity of human B cells: diverse functions, roles in autoimmunity, and use as therapeutic targets.

Authors:  Jennifer H Anolik; R John Looney; Frances E Lund; Troy D Randall; Iñaki Sanz
Journal:  Immunol Res       Date:  2009-04-07       Impact factor: 2.829

Review 9.  The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs).

Authors:  Gerwyn Morris; Michael Berk; Piotr Galecki; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-09-26       Impact factor: 5.590

Review 10.  Disease-modifying agents for multiple sclerosis: recent advances and future prospects.

Authors:  Til Menge; Martin S Weber; Bernhard Hemmer; Bernd C Kieseier; Hans-Christian von Büdingen; Clemens Warnke; Scott S Zamvil; Aaron Boster; Omar Khan; Hans-Peter Hartung; Olaf Stüve
Journal:  Drugs       Date:  2008       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.